A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial

Documenti analoghi

• Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors
  di: Kellye Eagan, et al.
  Pubblicazione: (2025)
• Factors That Influence Blood Pressure Changes With the Use of Sodium‐Glucose Cotransporter 2 Inhibitors in People With Type 2 Diabetes
  di: Sara Salama, et al.
  Pubblicazione: (2026)
• Multicenter study evaluating target attainment of anti‐Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients
  di: Tyler Chanas, et al.
  Pubblicazione: (2024)
• Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
  di: Maryam Aghakouchakzadeh, et al.
  Pubblicazione: (2026)
• Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Acinetobacter baumannii‐calcoaceticus complex
  di: Wesley D. Kufel, et al.
  Pubblicazione: (2025)